Income Statement GC Genome Corporation

Stocks

A340450

KR7340450006

Healthcare Facilities & Services

End-of-day quote Korea S.E. Other stock markets 10/08/2026			5-day change	1st Jan Change
5,470.00 ^KRW	+4.59%		+18.91%	-19.79%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
12/06/25	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

a1c57b.hSmMup_ICo6JAKt-8xVibAtmRWa-fkGdtbagoQ2Dzug.t13j6OqqcPjxM-UnkXZRCkkhHSfxCBDU5uL66UvA-9HDRcnu56Vr3uF1nw

Published financial data: GC GENOME CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	18.5B	24.11B	27.29B	25.89B	31.53B
Total Revenues	18.5B	24.11B	27.29B	25.89B	31.53B
Cost of Goods Sold, Total	11.32B	13.35B	13.59B	14.18B	16.91B
Gross Profit	7.18B	10.76B	13.7B	11.71B	14.63B
Selling General & Admin Expenses, Total	4.2B	5.56B	5.79B	6.46B	6.41B
Provision for Bad Debts	29.55M	-6.17M	-4.25M	7.42M	84.68M
R&D Expenses	4.84B	8.12B	7.36B	6.05B	6.48B
Depreciation & Amortization - (IS)	168M	237M	313M	324M	330M
Amortization of Goodwill and Intangible Assets - (IS)	29.1M	36.26M	35.12M	37.75M	40.45M
Other Operating Expenses	17.65M	47.85M	46.41M	54.31M	46.87M
Other Operating Expenses, Total	9.29B	14B	13.54B	12.94B	13.39B
Operating Income	-2.11B	-3.24B	160M	-1.23B	1.24B
Interest Expense, Total	-1.48B	-1.7B	-921M	-960M	-197M
Interest And Investment Income	297M	509M	482M	1.06B	1.22B
Net Interest Expenses	-1.19B	-1.19B	-438M	99.47M	1.02B
Income (Loss) On Equity Invest.	-	-	-	-	553M
Currency Exchange Gains (Loss)	-12.42M	-160M	-83.19M	882M	191M
Other Non Operating Income (Expenses)	3.73B	757M	-455M	248M	-541M
EBT, Excl. Unusual Items	420M	-3.83B	-816M	-3.2M	2.46B
Gain (Loss) On Sale Of Investments	-	-2.93M	-	-	1.83B
Gain (Loss) On Sale Of Assets	-13.83M	-44.89M	1.57M	1.36M	-139M
Asset Writedown	-	-	-	-1.13B	-
EBT, Incl. Unusual Items	407M	-3.87B	-815M	-1.13B	4.15B
Income Tax Expense	113M	-111M	-265M	130M	105M
Earnings From Continuing Operations	293M	-3.76B	-550M	-1.26B	4.04B
Net Income to Company	293M	-3.76B	-550M	-1.26B	4.04B
Net Income - (IS)	293M	-3.76B	-550M	-1.26B	4.04B
Net Income to Common Incl Extra Items	293M	-3.76B	-550M	-1.26B	4.04B
Net Income to Common Excl. Extra Items	293M	-3.76B	-550M	-1.26B	4.04B
Per Share Items
Net EPS - Basic	18.33	-232.9	-30	-69	184.57
Basic EPS - Continuing Operations	18.33	-232.9	-30	-69	184.57
Basic Weighted Average Shares Outstanding	16M	16.16M	18.34M	18.22M	21.91M
Net EPS - Diluted	18.33	-232.9	-30	-69	184.57
Diluted EPS - Continuing Operations	18.33	-232.9	-30	-69	184.57
Diluted Weighted Average Shares Outstanding	16M	29.02M	18.34M	18.22M	21.91M
Normalized Basic EPS	16.43	-147.99	-27.82	-0.11	70.16
Normalized Diluted EPS	16.43	-82.4	-27.82	-0.11	70.16
Supplemental Items
EBITDA	-51.89M	-429M	3.7B	1.99B	4.1B
EBITA	-2.03B	-3.15B	250M	-1.14B	1.34B
EBIT	-2.11B	-3.24B	160M	-1.23B	1.24B
EBITDAR	27.94M	-261M	3.86B	2.16B	4.31B
Effective Tax Rate - (Ratio)	27.88	2.85	32.47	-11.52	2.52
Normalized Net Income	263M	-2.39B	-510M	-2M	1.54B
Supplemental Operating Expense Items
Advertising Expense	97.65M	149M	143M	90.12M	149M
Selling and Marketing Expenses	559M	1.19B	928M	1.49B	1.23B
General and Administrative Expenses	229M	402M	244M	226M	197M
Research And Development Expense From Footnotes	4.84B	8.12B	7.36B	6.05B	6.48B
Net Rental Expense, Total	79.83M	168M	158M	172M	211M
Imputed Operating Lease Interest Expense	71.51M	185M	104M	161M	76.67M
Imputed Operating Lease Depreciation	8.32M	-16.48M	54.06M	11.23M	135M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	10.74B	13.64B	3.64B	6.53B	35.12B
Short Term Investments	15B	4B	5B	-	5B
Total Cash And Short Term Investments	25.74B	17.64B	8.64B	6.53B	40.12B
Accounts Receivable, Total	3.7B	4.22B	4.31B	5.44B	7B
Other Receivables	71M	325M	65.78M	12.94M	1.34B
Total Receivables	3.77B	4.55B	4.37B	5.45B	8.33B
Inventory	598M	1.2B	1.15B	1.22B	2B
Prepaid Expenses	126M	697M	292M	372M	374M
Other Current Assets, Total	30.69M	40.37M	96.29M	93.33M	149M
Total Current Assets	30.27B	24.12B	14.55B	13.66B	50.97B
Gross Property Plant And Equipment	12.13B	23.17B	26.28B	24.73B	23.46B
Accumulated Depreciation	-3.84B	-5.08B	-7.52B	-9.81B	-11.21B
Net Property Plant And Equipment	8.29B	18.09B	18.76B	14.92B	12.25B
Long-term Investments	1.65B	3.23B	6.1B	7.82B	17.38B
Other Intangibles, Total	618M	578M	533M	526M	529M
Accounts Receivable Long-Term	100	60	-380	10	-310
Deferred Tax Assets Long-Term	-	164M	680M	634M	857M
Other Long-Term Assets, Total	1.6B	2.71B	2.19B	3.06B	2.64B
Total Assets	42.43B	48.9B	42.82B	40.62B	84.63B
Liabilities
Accounts Payable, Total	1.29B	1.31B	852M	-	-
Accrued Expenses, Total	1.19B	1.83B	840M	110M	542M
Short-term Borrowings	-	-	6.56B	-	-
Current Portion of Leases	685M	997M	802M	792M	834M
Current Income Taxes Payable	-	-	-	-	221M
Unearned Revenue Current, Total	1.06B	1.22B	942M	1.5B	662M
Other Current Liabilities	485M	5.04B	2.99B	795M	482M
Total Current Liabilities	4.71B	10.39B	12.98B	3.2B	2.74B
Long-Term Debt	12.91B	5.82B	-	-	-
Long-Term Leases	508M	3.79B	4.4B	3.88B	3.18B
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	9M	-	-	-	-
Other Non Current Liabilities	5.32B	2.31B	396M	465M	428M
Total Liabilities	23.46B	22.31B	17.77B	7.54B	6.35B
Common Stock, Total	8B	9.07B	9.07B	9.78B	11.83B
Additional Paid In Capital	10.47B	21.01B	21.01B	29.89B	68.84B
Retained Earnings	492M	-3.24B	-3.96B	-5.28B	-1.15B
Comprehensive Income and Other	-	-248M	-1.07B	-1.31B	-1.25B
Total Common Equity	18.97B	26.59B	25.05B	33.08B	78.27B
Total Equity	18.97B	26.59B	25.05B	33.08B	78.27B
Total Liabilities And Equity	42.43B	48.9B	42.82B	40.62B	84.63B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16M	16.16M	18.34M	18.22M	23.65M
ECS Total Common Shares Outstanding	16M	16.16M	18.34M	18.22M	23.65M
Book Value / Share	1.19K	1.65K	1.37K	1.82K	3.31K
Tangible Book Value	18.35B	26.01B	24.51B	32.55B	77.74B
Tangible Book Value Per Share	1.15K	1.61K	1.34K	1.79K	3.29K
Total Debt	14.11B	10.6B	11.76B	4.67B	4.02B
Net Debt	-11.64B	-7.03B	3.12B	-1.86B	-36.1B
Debt Equivalent Oper. Leases	639M	1.35B	1.27B	1.38B	1.69B
Equity Method Investments, Total	-	-	-	-	9.7B
Inventories - Raw Materials, Total	598M	1.23B	1.2B	1.29B	2.1B
Inventories - Others	-30	50	-210	520	-60
Buildings, Total	1.11B	6.81B	7.73B	7.14B	6.91B
Machinery, Total	9.8B	11.33B	13.06B	12.81B	12.65B
Accumulated Allowance for Doubtful Accounts (Supple)	39.09M	32.92M	19.07M	26.3M	13.14M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	293M	-3.76B	-550M	-1.26B	4.04B
Depreciation & Amortization - CF	1.98B	2.72B	3.45B	3.13B	2.76B
Amortization of Goodwill and Intangible Assets - (CF)	76.48M	84.28M	90.07M	94.39M	102M
Depreciation & Amortization, Total	2.06B	2.81B	3.54B	3.22B	2.87B
(Gain) Loss From Sale Of Asset	13.83M	44.89M	-1.57M	-1.36M	139M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-1.83B
Asset Writedown & Restructuring Costs	-	-	-	1.13B	-
(Income) Loss On Equity Investments - (CF)	-	2.93M	-	-	-553M
Stock-Based Compensation (CF)	-	-	-	-	586M
Provision and Write-off of Bad Debts	29.55M	-6.17M	-4.25M	7.42M	84.68M
Other Operating Activities, Total	-1.22B	1.9B	1.7B	-177M	-60.97M
Change In Accounts Receivable	-2.13B	-518M	-83.41M	-1.13B	-1.64B
Change In Inventories	-610M	-618M	30.87M	-97.71M	-802M
Change In Accounts Payable	1.29B	17.83M	-460M	-852M	-
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	208M	-1.47B	-834M	-457M	-1.54B
Cash from Operations	-67.7M	-1.61B	3.34B	378M	1.3B
Capital Expenditure	-2.87B	-4.03B	-7.41B	-329M	-311M
Sale of Property, Plant, and Equipment	-	814M	-	-	5.86M
Sale (Purchase) of Intangible assets	-169M	-40.7M	-49.42M	-87.11M	-42.99M
Investment in Marketable and Equity Securities, Total	5.24B	8.95B	-4.97B	3.82B	-11.95B
Other Investing Activities, Total	-303M	-517M	-55.46M	-276M	-184M
Cash from Investing	1.9B	5.18B	-12.48B	3.13B	-12.48B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-490M	-672M	-859M	-616M	-664M
Total Debt Repaid	-490M	-672M	-859M	-616M	-664M
Issuance of Common Stock	-	-	-	-	40.44B
Cash from Financing	-490M	-672M	-859M	-616M	39.77B
Foreign Exchange Rate Adjustments	-	-994K	-5.41M	5.69K	38.6K
Miscellaneous Cash Flow Adjustments	10	-	-	-	-
Net Change in Cash	1.34B	2.89B	-10B	2.89B	28.59B
Supplemental Items
Cash Interest Paid	30.66M	-	173M	211M	186M
Cash Income Tax Paid (Refund)	31.28M	-54.92M	-3.1M	-2.53M	58.45M
Levered Free Cash Flow	-3.85B	-933M	-7.6B	-3B	-1.05B
Unlevered Free Cash Flow	-2.92B	126M	-7.02B	-2.4B	-932M
Change In Net Working Capital	621M	-3.41B	3.21B	4.43B	4.22B
Net Debt Issued / Repaid	-490M	-672M	-859M	-616M	-664M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-3.13	-4.43	0.22	-1.85	1.23
Return on Total Capital	-4.11	-5.76	0.27	-2.07	1.29
Return On Equity %	1.56	-16.52	-2.13	-4.32	7.26
Return on Common Equity	1.56	-16.52	-2.13	-4.32	7.26
Margin Analysis
Gross Profit Margin %	38.81	44.64	50.19	45.22	46.39
SG&A Margin	22.73	23.07	21.22	24.97	20.34
EBITDA Margin %	-0.28	-1.78	13.56	7.67	13.01
EBITA Margin %	-10.99	-13.07	0.92	-4.4	4.24
EBIT Margin %	-11.4	-13.42	0.59	-4.76	3.92
Income From Continuing Operations Margin %	1.58	-15.61	-2.02	-4.86	12.83
Net Income Margin %	1.58	-15.61	-2.02	-4.86	12.83
Net Avail. For Common Margin %	1.58	-15.61	-2.02	-4.86	12.83
Normalized Net Income Margin	1.42	-9.92	-1.87	-0.01	4.87
Levered Free Cash Flow Margin	-20.79	-3.87	-27.83	-11.59	-3.35
Unlevered Free Cash Flow Margin	-15.78	0.52	-25.72	-9.28	-2.95
Asset Turnover
Asset Turnover	0.44	0.53	0.6	0.62	0.5
Fixed Assets Turnover	2.48	1.83	1.48	1.54	2.32
Receivables Turnover (Average Receivables)	6.97	6.09	6.4	5.31	5.07
Inventory Turnover (Average Inventory)	-	14.85	11.56	11.96	10.51
Short Term Liquidity
Current Ratio	6.42	2.32	1.12	4.27	18.59
Quick Ratio	6.26	2.13	1	3.74	17.67
Operating Cash Flow to Current Liabilities	-0.01	-0.15	0.26	0.12	0.47
Days Sales Outstanding (Average Receivables)	52.36	59.97	57.02	68.89	71.97
Days Outstanding Inventory (Average Inventory)	-	24.58	31.57	30.6	34.72
Average Days Payable Outstanding	-	34.08	29.14	-	-
Cash Conversion Cycle (Average Days)	-	50.47	59.46	-	-
Long Term Solvency
Total Debt/Equity	74.37	39.89	46.94	14.12	5.13
Total Debt / Total Capital	42.65	28.51	31.94	12.37	4.88
LT Debt/Equity	70.76	36.14	17.56	11.72	4.07
Long-Term Debt / Total Capital	40.58	25.83	11.95	10.27	3.87
Total Liabilities / Total Assets	55.3	45.63	41.5	18.57	7.51
EBIT / Interest Expense	-1.42	-1.91	0.17	-1.29	6.27
EBITDA / Interest Expense	-0.04	-0.25	4.02	2.07	20.81
(EBITDA - Capex) / Interest Expense	-1.97	-2.63	-4.02	1.73	19.23
Total Debt / EBITDA	-271.85	-24.72	3.18	2.35	0.98
Net Debt / EBITDA	224.25	16.39	0.84	-0.94	-8.8
Total Debt / (EBITDA - Capex)	-4.83	-2.38	-3.17	2.82	1.06
Net Debt / (EBITDA - Capex)	3.99	1.58	-0.84	-1.12	-9.52
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	36.46	30.36	13.18	-5.15	21.81
Gross Profit, 1 Yr. Growth %	17.72	49.93	27.24	-14.53	24.96
EBITDA, 1 Yr. Growth %	-105.3	726.74	-962.65	-46.34	106.58
EBITA, 1 Yr. Growth %	-3.7K	55.05	-107.94	-555.37	-217.45
EBIT, 1 Yr. Growth %	77.25K	53.42	-104.95	-870.57	-200.17
Earnings From Cont. Operations, 1 Yr. Growth %	-11.07K	-1.38K	-85.38	128.49	-421.77
Net Income, 1 Yr. Growth %	-11.07K	-1.38K	-85.38	128.49	-421.77
Normalized Net Income, 1 Yr. Growth %	-1.23K	-1.01K	-78.67	-99.61	-77.06K
Diluted EPS Before Extra, 1 Yr. Growth %	-12.32K	-1.37K	-87.12	130	-367.5
Accounts Receivable, 1 Yr. Growth %	130.77	14.01	2.03	26.29	28.64
Inventory, 1 Yr. Growth %	-	100.57	-3.97	5.78	63.88
Net Property, Plant and Equip., 1 Yr. Growth %	24.85	118.2	3.67	-20.47	-17.86
Total Assets, 1 Yr. Growth %	1.39	15.24	-12.43	-5.13	108.32
Tangible Book Value, 1 Yr. Growth %	1.69	41.74	-5.74	32.79	138.82
Common Equity, 1 Yr. Growth %	1.69	40.17	-5.78	32.07	136.62
Cash From Operations, 1 Yr. Growth %	-110.12	2.28K	-307.42	-88.68	243.12
Capital Expenditures, 1 Yr. Growth %	18.68	40.49	83.82	-95.56	-5.24
Levered Free Cash Flow, 1 Yr. Growth %	62.31	-75.73	713.88	-60.49	-64.85
Unlevered Free Cash Flow, 1 Yr. Growth %	27.24	-104.33	-5.66K	-65.8	-61.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.36	33.37	21.47	3.61	7.49
Gross Profit, 2 Yr. CAGR %	16.86	32.85	38.12	4.28	3.34
EBITDA, 2 Yr. CAGR %	-78.61	-33.78	744.5	115.16	5.29
EBITA, 2 Yr. CAGR %	125.83	646.99	-64.92	-39.88	131.26
EBIT, 2 Yr. CAGR %	144.28	3.34K	-72.45	-38.26	177.83
Earnings From Cont. Operations, 2 Yr. CAGR %	12.07	3.65K	36.97	-42.21	171.15
Net Income, 2 Yr. CAGR %	12.07	3.65K	36.97	-42.21	171.15
Normalized Net Income, 2 Yr. CAGR %	19.06	914.33	39.33	-97.11	73.6
Diluted EPS Before Extra, 2 Yr. CAGR %	-14.37	3.84K	27.93	-45.58	148.04
Accounts Receivable, 2 Yr. CAGR %	67.67	62.2	7.85	13.51	27.46
Inventory, 2 Yr. CAGR %	-	-	38.78	0.79	31.67
Net Property, Plant and Equip., 2 Yr. CAGR %	30.91	65.05	50.4	-9.2	-19.18
Total Assets, 2 Yr. CAGR %	74.03	8.09	0.46	-8.85	40.58
Tangible Book Value, 2 Yr. CAGR %	49.72	20.06	15.59	11.88	78.08
Common Equity, 2 Yr. CAGR %	48.34	19.39	14.92	11.55	76.77
Cash From Operations, 2 Yr. CAGR %	-72.5	55.16	602.43	-51.55	-37.69
Capital Expenditures, 2 Yr. CAGR %	46.81	29.13	60.7	-71.44	-79.49
Levered Free Cash Flow, 2 Yr. CAGR %	-	-37.24	40.54	79.32	-62.73
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-76.53	55.07	335.94	-63.57
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	25.65	26.27	11.86	9.35
Gross Profit, 3 Yr. CAGR %	-	26.98	30.96	17.7	10.76
EBITDA, 3 Yr. CAGR %	-	-27.67	55.82	237	112.26
EBITA, 3 Yr. CAGR %	-	99.22	64.23	-17.55	-24.84
EBIT, 3 Yr. CAGR %	-	109.19	288.66	-16.37	-27.45
Earnings From Cont. Operations, 3 Yr. CAGR %	-	152.62	490.37	62.45	2.43
Net Income, 3 Yr. CAGR %	-	152.62	490.37	62.45	2.43
Normalized Net Income, 3 Yr. CAGR %	-	134.53	179.99	-80.34	-13.69
Diluted EPS Before Extra, 3 Yr. CAGR %	-	110.41	484.8	55.56	-7.47
Accounts Receivable, 3 Yr. CAGR %	-	47.44	38.98	13.68	18.35
Inventory, 3 Yr. CAGR %	-	-	-	26.77	18.52
Net Property, Plant and Equip., 3 Yr. CAGR %	-	55.21	41.35	21.62	-12.18
Total Assets, 3 Yr. CAGR %	-	51.69	0.77	-1.44	20.06
Tangible Book Value, 3 Yr. CAGR %	-	47.01	10.76	21.06	44.05
Common Equity, 3 Yr. CAGR %	-	45.57	10.33	20.37	43.33
Cash From Operations, 3 Yr. CAGR %	-	21.61	70.92	77.4	-6.96
Capital Expenditures, 3 Yr. CAGR %	-	44.68	45.26	-51.43	-57.4
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	47.45	-7.93	4.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	45.18	-6.3	94.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	16.32	18.39
Gross Profit, 5 Yr. CAGR %	-	-	-	17.36	19.12
EBITDA, 5 Yr. CAGR %	-	-	-	11.87	33.21
EBITA, 5 Yr. CAGR %	-	-	-	23.37	88.33
EBIT, 5 Yr. CAGR %	-	-	-	28.4	239.82
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	40.03	332.47
Net Income, 5 Yr. CAGR %	-	-	-	40.03	332.47
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-59.59	131.26
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	22.51	314.97
Accounts Receivable, 5 Yr. CAGR %	-	-	-	32.8	34.25
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	25.25	13.03
Total Assets, 5 Yr. CAGR %	-	-	-	23.73	15.12
Tangible Book Value, 5 Yr. CAGR %	-	-	-	31.8	33.93
Common Equity, 5 Yr. CAGR %	-	-	-	30.86	33.22
Cash From Operations, 5 Yr. CAGR %	-	-	-	-15.84	14.16
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-24.4	-33.62
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-14.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-16.49